Sanofi-Aventis has recalled 30 batches of the anticoagulant Clexane (enoxaparin). The move was made after quality control tests found there was the possibility that there could be an over-concentration of the active ingredient in a limited number of syringes.
FULL STORY

Source: Pharmaceutical industry, medical sales & NHS related news